Field & Main Bank Has $3.30 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Field & Main Bank trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 8,457 shares of the healthcare conglomerate’s stock after selling 510 shares during the quarter. UnitedHealth Group comprises 2.2% of Field & Main Bank’s investment portfolio, making the stock its 10th largest position. Field & Main Bank’s holdings in UnitedHealth Group were worth $3,304,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SignalPoint Asset Management LLC grew its holdings in shares of UnitedHealth Group by 3.1% during the second quarter. SignalPoint Asset Management LLC now owns 786 shares of the healthcare conglomerate’s stock worth $315,000 after buying an additional 24 shares in the last quarter. Davis Rea LTD. boosted its position in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Davis Rea LTD. now owns 6,782 shares of the healthcare conglomerate’s stock valued at $2,716,000 after acquiring an additional 25 shares during the last quarter. Tandem Capital Management Corp ADV boosted its position in shares of UnitedHealth Group by 0.9% during the 2nd quarter. Tandem Capital Management Corp ADV now owns 2,693 shares of the healthcare conglomerate’s stock valued at $1,078,000 after acquiring an additional 25 shares during the last quarter. Foster Group Inc. boosted its position in shares of UnitedHealth Group by 1.0% during the 2nd quarter. Foster Group Inc. now owns 2,466 shares of the healthcare conglomerate’s stock valued at $987,000 after acquiring an additional 25 shares during the last quarter. Finally, Waters Parkerson & CO. LLC lifted its position in UnitedHealth Group by 3.2% in the second quarter. Waters Parkerson & CO. LLC now owns 807 shares of the healthcare conglomerate’s stock valued at $323,000 after buying an additional 25 shares during the last quarter. 86.20% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts have commented on UNH shares. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $421.00 to $477.00 and gave the company a “buy” rating in a research report on Tuesday, November 16th. SVB Leerink assumed coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They set an “outperform” rating and a $480.00 price target on the stock. Cowen assumed coverage on shares of UnitedHealth Group in a research report on Thursday, September 9th. They set an “outperform” rating and a $478.00 price target on the stock. Mizuho increased their price target on shares of UnitedHealth Group from $455.00 to $500.00 and gave the stock a “buy” rating in a research report on Wednesday, November 10th. Finally, Oppenheimer increased their price target on shares of UnitedHealth Group from $465.00 to $475.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. One equities research analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $477.35.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction dated Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total transaction of $1,111,750.00. The disclosure for this sale can be found here. Insiders have sold 82,500 shares of company stock valued at $36,855,125 over the last three months. 0.55% of the stock is currently owned by corporate insiders.

Shares of NYSE:UNH traded up $3.03 on Thursday, reaching $450.16. The company’s stock had a trading volume of 2,248,836 shares, compared to its average volume of 2,940,181. The stock has a market capitalization of $423.98 billion, a P/E ratio of 27.93, a PEG ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a 52-week low of $320.35 and a 52-week high of $466.00. The stock’s 50-day moving average is $430.47 and its two-hundred day moving average is $418.01. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.41 by $0.11. The firm had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the prior year, the company posted $3.51 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be issued a dividend of $1.45 per share. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s dividend payout ratio is currently 35.98%.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: Non-Fungible Token (NFT)

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.